Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will announce results of its first quarter ended March 31, 2014 before market trading hours on Thursday, May 8, 2014. A conference call to discuss the company’s first quarter results and the company’s operations is scheduled for that same day at 11:00 AM (Eastern Time).
Help employers find you! Check out all the jobs and post your resume.
